MNMIP1 and hepatocellular carcinoma: To aid clinicians assess patients’ prognoses based on the aforementioned parameters, we established a nomograph of different prognostic factors including SH3D21 expression, patient age, gender, hepatocellular carcinoma stage, grade, and several other variables to predict the OS of the patients (Fig 9C).